Sulfonylureas: A Widely Used Oral Anti-Hyperglycaemic Medication for Type 2 Diabetes Management

D Mohajan, HK Mohajan - Journal of Innovations in Medical …, 2024 - paradigmpress.org
Diabetes mellitus (DM) is a fast growing epidemic and a public health concern all over the
world due to its increased incidence and its devastating complications. Sulfonylureas (SUs) …

Präoperative Evaluation erwachsener Patientinnen und Patienten vor elektiven, nicht herz-thoraxchirurgischen Eingriffen

C Zöllner - Die Anaesthesiologie, 2024 - Springer
Die 70 Empfehlungen fassen den aktuellen Stand der präoperativen Risikoevaluation von
erwachsenen Patientinnen und Patienten vor elektiven, nicht herz-thoraxchirurgischen …

Effects of initial combinations of gemigliptin plus metformin compared with glimepiride plus metformin on gut microbiota and glucose regulation in obese patients with …

S Lim, M Sohn, JC Florez, MA Nauck, J Ahn - Nutrients, 2023 - mdpi.com
The efficacy and safety of medications can be affected by alterations in gut microbiota in
human beings. Among antidiabetic medications, incretin-based therapy such as dipeptidyl …

[HTML][HTML] Glimepiride and metformin combinations in diabetes comorbidities and complications: real-world evidence

RK Sahay, V Mittal, GR Gopal, S Kota, G Goyal… - Cureus, 2020 - ncbi.nlm.nih.gov
Objective To evaluate the usage of various strengths of glimepiride and metformin fixed-
dose combinations in the management of type 2 diabetes mellitus (T2DM) patients with …

Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation

B Haas, MDS Hass, A Voltz, M Vogel, J Walther… - Molecular …, 2024 - Elsevier
Abstract Objective Sulfonylureas (SUs) are still among the mostly prescribed antidiabetic
drugs with an established mode of action: release of insulin from pancreatic β-cells. In …

Associations among diabetes medication use, serum magnesium, and insulin resistance in a cohort of older Puerto Rican adults

F Chen, KM Mangano, M Garelnabi… - The American Journal of …, 2024 - Elsevier
Background Hypomagnesemia is commonly observed in individuals with diabetes, but how
diabetes medications alter magnesium (Mg) status remains unclear. Objectives We aimed to …

Need of single pill fixed-dose combination with glimepiride in management of diabetes mellitus

S Tripathi, M Tiwaskar, S Kota, G Parthan… - Journal of the …, 2019 - mdrf-eprints.in
The progressive nature of type 2 diabetes mellitus (T2DM) mostly leads to insufficient
glycemic control in people on monotherapy, over long periods of time. This necessitates the …

Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19

A An, A Baghela, P Zhang, TM Blimkie, J Gauthier… - bioRxiv, 2023 - biorxiv.org
Background: COVID-19 patients experience dynamic changes in immune and cellular
function over time with potential clinical implications. However, there is insufficient research …

Usage pattern of glimepiride/metformin fixed-dose combination in type 2 diabetes patients with CVD or at risk of CVD: an experience in Indian setting

S Ray, K Ganguly, MS Rao, S Sinha, YS Kumar… - Asian Journal of …, 2022 - ojs.ijcp.in
Background: Diabetes is associated with almost twofold increased risk of cardiovascular
diseases (CVD). The present case-based questionnaire survey evaluated the treatment …

[HTML][HTML] Expert consensus recommendations on the evaluation and management of hypoglycemia in diabetes: DGENius Group Diabetes India

AK Dey, R Gokalani, M Kale, P Sankar… - Journal of …, 2024 - journals.lww.com
Materials and Methods: The consensus statement was crafted through an extensive
literature review involving peer-reviewed articles, clinical guidelines, and relevant …